||EPS - Basic
||Market Cap (m)
|Pharmaceuticals & Biotechnology
Real-Time news about Goldshield Grp (London Stock Exchange): 0 recent articles
|simon gordon: Just for the entertainment value this stock is a great story on how a family shareholding can stymie proper business growth.
I laughed harder when I saw they had enisted Tony Blair's former drug czar as Chairman. What have the Board been smoking? I suppose they appointed him for his hardcore business flair.
If the bank or private equity don't lend them the money for an MBO then the share price should drop below £2.00.
I would not lend them a penny for the Wellbeing Clinics in India.
They should pour the cashflow into buying drugs to sell through the existing distribution channel. KISS.|
|old giggleswickian: Lossman,
You will often find people on bulletin board who "know" something when they don't so I shall make no claim, however, I see the investigation as a positive point from the standpoint of a new investor because it has at least contributed in some way to the present low price relative to the past. I believe that the matter will be resolved and that the effect on the share price will be positive.
It is only on rare occasions that I try to make short term gains (as short as a month) in the way that I am presently atempting with ISYS, I would rather take my chances on a company that has had its problems but is fundamentally sound and will grow over the long term. I think that GSD falls in to this catagory.
|jtcod: I found it rather ironic to receive an RNS statement giving shareholders a 'PR spin' on recent NHS procurement changes this morning.
The company originally set the AGM for July 2003(as per previous years). Then they set it back to 29th August 2003. Presumably because things had not improved. Incredibly, given the problems of the last 12 months, no RNS trading update has been released for Friday's AGM. There is no firm LSE requirement on this subject but it is expected that the company should report any material change in trading (Good or Bad).
Lets face it, if things were improved they would have trumpeted it via every corner of the press. So I have to conclude that things are no better (And that's the best case scenario).
I rather suspect though that the management is too scarred to release any information that may have a negative impact on the share price. If so, they are playing a very dangerous game.
If things have deteriorated, and they have not used the AGM in order to inform shareholders of such they are in deep water and shareholders would have a right to be very vocal indeed to the FSA.
I hope things still improve for the company in the long run but the lack of an RNS for the AGM does not bode well.
As ever, all in my humble opinion and DYOR
|morjarias: JT, I respect and agree with your view regarding the medium to long-term prospects of GSD as a company. However, it might be worthwhile to not overlook short-term trading opportunities - the share price is deep in oversold territory according to RSI - personally I was disappointed with the way the price just fell without any warning! On the face of it, it is not encouraging - but look at the actions of Fund Managers - Schroder owns 20%, the Miner's Pension fund have raised their stakes to nearly 5% - simply on reduced supply of the stock, the prices should see a correction upwards.
Looking at the 6 monthly bar charts, you'll notice that 'intra-day', the price bounced off the 117-120 level twice - with the 'neck line at 170 approximately, if crossed, we are looking at 223p! 190 level may be broken with ease.
You might be able to recoup your losses! Atleast consider it!! Good Luck :)|
|cyber investor: I'm not long or short - I just think that the company will make an announcement in an attempt to halt the share price slide
Just wondering if it will be worth jumping in for the bounce|
Goldshield share price data is direct from the London Stock Exchange